findmyKOL
Clinical trialNCT02465450CompletedPhase 2Interventional

Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis

SponsorCorbus Pharmaceuticals Inc.Enrollment85Cystic Fibrosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • J S Elborn, M.D.

    Queens University, Belfast, Northern Ireland, United Kingdom

    Principal Investigator
  • James Chmiel, M.D.

    University Hospitals Cleveland Medical Center, Cleveland, OH

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Hôpital Erasme

    Brussels, Belgium

France
  • Hôpital Arnaud de Villeneuve

    Montpellier, France

  • Institution Hôpital Pasteur

    Nice, France

  • Centre de Perharidy

    Roscoff, France

Germany
  • Christiane Herzog Cf-Zentrum Frankfurt Am Main

    Frankfurt am Main, Hesse, Germany

  • Uni Essen Abt.Pneumologie

    Essen, North Rhine-Westphalia, Germany

Italy
  • Fondazione Irccs Ca' Granda - Ospedale Maggiore Policlinico

    Milan, Italy

  • Fondazione Irccs Cà Granda Ospedale Maggiore Policlinico

    Milan, Italy

  • Aoui Di Verona - Ospedale Borgo Trento Uoc Fibrosi Cistica

    Verona, Italy

Poland
  • Szpital Dziecięcy Polanki Im. Macieja Płażyńskiego W Gdańsku Spółka Z O.O. Poradnia Leczenia Mukowiscydozy

    Gdansk, Poland

  • Sanatorium Cassia-Villa Medica S.C

    Rabka-Zdrój, Poland

  • Podkarpacki Ośrodek Pulmunologii I Alergologii

    Rzeszów, Poland

  • Instytut Gruźlicy I Chorób Płuc I Klinika Chorób Płuc

    Warsaw, Poland

United Kingdom
  • Belfast City Hospital

    Belfast, United Kingdom

  • Queen Elizabeth University Hospital

    Glasgow, United Kingdom

United States
  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, United States

  • Long Beach Memorial Medical Center/miller Children'S and Women'S Hospital

    Long Beach, California, United States

  • National Jewish Health

    Denver, Colorado, United States

  • Boston Children'S Hospital

    Boston, Massachusetts, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Rutgers Robert-Wood Johnson Medical School

    New Brunswick, New Jersey, United States

  • North Shore Lij Health System

    New Hyde Park, New York, United States

  • New York Medical College

    Valhalla, New York, United States

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • the University of Texas Southwestern Medical Center

    Dallas, Texas, United States

  • Texas Children'S Hospital Clinical Care Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Sept 2015
Primary completion
28 Dec 2016
Completion
28 Dec 2016
Last update posted
4 Apr 2018
Registered enrollment
85
Registry id
NCT02465450

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.